FASN inhibition sensitizes metastatic OSCC cells to cisplatin and paclitaxel by downregulating cyclin B1.
Almeida LY, Moreira FDS, Santos GASD, Cuadra Zelaya FJM, Ortiz CA, Agostini M, Mariano FS, Bastos DC, Daher URN, Kowalski LP, Coletta RD, Graner E.
Almeida LY, et al. Among authors: graner e.
Oral Dis. 2023 Mar;29(2):649-660. doi: 10.1111/odi.14017. Epub 2021 Sep 29.
Oral Dis. 2023.
PMID: 34510641